| SPRY Market Cap History Table | ||||||||||||||||||||||||||||||
Below is a table of the SPRY market cap history going back to 10/31/2022:
Also see: SPRY Shares Outstanding History and SPRY YTD Return |
SPRY Market Cap History — ARS Pharmaceuticals Capitalization Over Time
As of 5/13/2026 ARS Pharmaceuticals has a market cap of 795.42 million. Investors often follow the SPRY market cap history to compare the size of the company over time.
This page shows SPRY market capitalization trends over time, with 14 market cap datapoints presented, dating back to 10/31/2022.
| SPRY Market Cap History Chart | |||||||||||||||||||||||||||||||
SPRY Historical Market Cap: +43.07% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||
| SPRY Stock Price Chart |
| About ARS Pharmaceuticals Inc |
| ARS Pharmaceuticals, Inc. is a biopharmaceutical company. Co. is focused on developing neffy, for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, administered and nasal spray. Type I allergic reactions are potentially life-threatening hypersensitivity reactions that can occur within minutes of exposure to an allergen and need to be treated immediately to relieve symptoms and prevent further progression. We show 14 historical shares outstanding datapoints in our SPRY shares outstanding history coverage, used to compute SPRY market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SPRY market cap history over the course of time is important for investors interested in comparing SPRY's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SPRY versus a peer is one thing; comparing SPRY market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SPRY can fluctuate over the course of history. With this page we aim to empower investors researching SPRY by allowing them to research the SPRY market cap history. |
| SPRY Current Stock Quote |
Quotes delayed 20 minutes  Free SPRY Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| SPRY Share Performance |
| Market Cap Peers |
| ARS Pharmaceuticals (SPRY) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
SQL Market Cap History SQZ Market Cap History SRDX Market Cap History SRGA Market Cap History SRNE Market Cap History SRPT Market Cap History SRRA Market Cap History SRRK Market Cap History SRTS Market Cap History SRZN Market Cap History More Healthcare companies » |
SPRY Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
